Carbetapentane and pseudoephedrine and Necitumumab Intravenous
Determining the interaction of Carbetapentane and pseudoephedrine and Necitumumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: carbetapentane / pseudoephedrine
Brand name: Respi-TANN, Respi-Tann Pd, Re-Tann, Carb Pseudo-Tan, Allres PD, Allres D, Pseudacarb, Corzall
Synonyms: n.a.
Generic Name: necitumumab
Brand name: Portrazza
Synonyms: Necitumumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Carbetapentane and pseudoephedrine-Necon
- Carbetapentane and pseudoephedrine-Necon 0.5/35
- Carbetapentane and pseudoephedrine-Necon 1/35
- Carbetapentane and pseudoephedrine-Necon 1/50
- Carbetapentane and pseudoephedrine-Necon 1/50 (28)
- Carbetapentane and pseudoephedrine-Necon 7/7/7
- Necitumumab Intravenous-Carbidopa
- Necitumumab Intravenous-Carbidopa and levodopa
- Necitumumab Intravenous-Carbidopa and levodopa enteral
- Necitumumab Intravenous-Carbidopa and Levodopa Enteral Suspension
- Necitumumab Intravenous-Carbidopa and Levodopa Extended-Release Capsules
- Necitumumab Intravenous-Carbidopa and Levodopa Extended-Release Tablets